. These requantitative aspects of the mechanism of HbS polymerizacombinant hemoglobins were extensively characterized by tion and in identifying the contribution of individual sites to high-performance liquid chromatography analysis, sodium the overall process. The strategy described here demondodecyl sulfate-polyacrylamide gel electrophoresis, isoelecstrates the feasibility of a systematic approach to achieve tric focusing, amino acid analysis, and mass spectroscopy.
T
in a progressive fashion would provide a comprehensive and quantitative appreciation of the role of various sites in HbS HE LACK OF A naturally occurring animal model for sickle cell disease to test the efficacy of pharmacologic agents for treatment of the disease has prompted the developpolymerization to complement the x-ray 8 and electron microscopic results, 9 ,10 which identify the sites of polymerization ment of transgenic mice in which the gene encoding sickle hemoglobin (HbS) is expressed in their red blood cells but do not address their contribution to polymerization. Studies on the effects of such mutants on the well-known kinetics (RBCs). Several variations of this model have been developed, [1] [2] [3] [4] [5] [6] ie, mice expressing additional mutant Hbs together of polymerization 11 may also provide new information. Accordingly, we report here the expression and study of three with HbS, ie, the SAD mouse model expressing HbS, Hb Antilles, and Hb D-Punjab. However, the continued expresrecombinant HbS mutants with enhanced polymerization properties. sion of mouse Hb in such RBCs interferes with the polymerization of HbS or the higher mutants of HbS, thus impeding
There are a number of natural Hbs that inhibit polymerization, and this information was used initially to identify the the formation of morphologically sickled erythrocytes to the extent that they appear in the circulation of sickle cell anemia contact sites between HbS tetramers in the polymer. 12 Currently, information on polymerization enhancing mutants is patients. Attempts to delete the endogenous mouse Hb genes are underway to circumvent this problem. Moreover, the limited to a small number of naturally occurring Hb double mutants 12 that were identified because their presence in the sickle mouse model has proven useful for studying other problems associated with sickle cell anemia. 7 RBC together with HbS led to a more severe clinical state than homozygous sickle cell disease. 13 Furthermore, the moBecause the strategy of using multiple naturally occurring HbS variants is now an accepted experimental route, we lecular basis for understanding the enhanced polymerization properties of these mutants is not understood. The availabilhave taken the approach that the presence of higher order recombinant mutant Hbs in mouse RBCs with even more ity of recombinant DNA technology greatly expands the possibilities of enlarging that base of information and also pronounced polymerization properties than HbS itself may be a viable strategy. Furthermore, the study of such mutants to substitute a variety of amino acids at any given site to achieve either an enhanced or a reduced polymerization. The current transgenic mouse models for sickle cell anemia are based on the enhanced polymerization of certain (DPG)  GTC CAC GTG and the 5-CAC GTG GAC TAC ATG CCC AAC  G and 5-GAA CAA AGT CGA CTT AAC GGT A, respectively. were purchased from Sigma (St Louis, MO). The nucleotides used to make the mutations were synthesized by the Protein Sequencing
The underlined bases were those used to create the desired mutations Asp6 (a) r Ala and Asp75 (a) r Tyr. PCR amplifications were Facility at the Rockefeller University (New York, NY). The construction of pGS189 and pGS389 plasmids has been described elseperformed as described above to produce the recombinant a-globin gene containing the D6A(a) and D75Y(a) mutations. The recombiwhere.
14, 15 All the other reagents were of the highest purity available.
Polymerase chain reaction (PCR)-based site-directed mutagenesis
nant a-globin gene was excised as the Nco I and Sal I fragment and used to replace the Nco I and Sal I fragment of pAD190. The of the double HbS mutant E6V(b)/E121R(b). An Xho I fragment of pGS189 containing the sickle b-globin cDNA was inserted into recombinant plasmid with desired mutations was identified directly by DNA sequence analysis and the base change encoding the Asp6 the Xho I site of Bluescript II SK (/) to produce a plasmid with 4.2 kb, BSK-Beta E6V(b) . 16, 17 This plasmid was used as a template in (a) r Ala and Asp75 (a) r Tyr was the only mutation of the aglobin gene. The Sph I fragment of plasmid pGS189 E6V(b)/E121R(b) was the PCR reactions. The two synthetic oligonucleotides (5-AC TTT GGC AAA MGR TTC ACC CCA CCA GTG C and 5-G CAC excised and inserted into Sph I site of pAD190 D6A(a)/D75Y(a) to produce a plasmid with a-and b-genes, pAD190
. TGG TGG GGT GAA YCK TTT GCC AAA GT) were used for the PCR amplifications, and the underlined bases were those used This a and b cassette was excised as Not I fragment and similarly inserted into the Not I site of pGS389 to give the recombinant to create the desired mutation. M denotes a mixture of A / C and Y denotes a mixture of C / T. These two primers were used in two plasmid, pGS389
. Yeast expression system and purification of Hb mutants. The PCR reactions to generate two PCR fragments. PCR amplifications were performed on a GeneAmp PCR system 2400 (Perkin-Elmer, recombinant pGS389
, pGS389
, and pGS389 D6A(a)/D75Y(a)/E6V(b)/E121R(b) were transformed into SaccharoNorwalk, CT) with 25 cycles of 30 seconds of denaturation at 97ЊC, 1 minute of primer/template annealing at 55ЊC, and 1 minute of myces cerevisiae GSY112 cirЊ strain, using the lithium acetate method described previously. [15] [16] [17] [18] The transformants were selected extension at 72ЊC. These two fragments were then recombined in a separate PCR reaction, with primer/template annealing at 45ЊC, to using a complete medium first without uracil and then without uracil and leucine. To express each recombinant mutant, the yeast strain produce recombinant sickle b gene containing the E121R(b) mutation. From this recombinant DNA fragment, the BamHI fragment was grown in 12 L YP medium in a New Brunswick (Edison, NJ) Fermentor Bio IV for 3 to 4 days, using ethanol as the carbon source was excised and used to replace the BamHI fragment of BSKBeta E6V(b) . The correct insertional direction of the mutated BamHI until an absorbance at 600 nm in the range of 5 to 10 was reached.
The promoter controlling the transcription of the globin genes was fragment in BSK-Beta E6V(b) was verified by restriction enzyme analysis. The recombinant plasmid with desired mutation was identified induced for 20 hours by adding galactose (Pfanstiehl [Waukegan, IL] or US Biochemicals containing õ0.1% glucose) to a final condirectly by DNA sequence analysis and the base change encoding the Glu121(b) r Arg was the only mutation of the sickle b-globin centration of 3%. The collection and breakage of the cells after bubbling with CO gas has been described previously. [15] [16] [17] [18] The purifigene. The b-globin cDNA with the base change encoding the Glu6(b) r Val and Glu121(b) r Arg was isolated as an Xho I cation of the double mutant Hb was accomplished by chromatography on CM-Cellulose 52, using the linear gradient that consisted of fragment and used to replace the Xho I fragment of pGS189. The resulting plasmid pGS189 E6V(b)/E121R(b) was digested with Not I and 10 mmol/L potassium phosphate, pH 5.8, and 25 mmol/L potassium phosphate, pH 8.0 (150 mL of each). The purification of the triple Bgl I to release the a-and b-gene cassette. The cassette was purified from agarose gel using a Geneclean kit (Bio 101) and inserted into mutant was accomplished using the linear gradient that consisted of 10 mmol/L potassium phosphate, pH 5.8, and 50 mmol/L potassium pGS389 previously digested with Not I to give the recombinant plasmid, pGS389
.
phosphate, pH 8.5 (150 mL of each). The quadruple mutant was initially chromatographed on CM-Cellulose 52 using the linear gra-
PCR-based site-directed mutagenesis of the triple HbS mutant D75Y(a)/E6V(b)/E121R(b).
The plasmid pAD190, which was dient that consisted of 10 mmol/L potassium phosphate, pH 5.8, and 50 mmol/L potassium phosphate, pH 8.5 (150 mL of each). The constructed by Dr A. Dumoulin in our laboratory as a derivative of pGS189, was used as a template in the PCR reactions to create the main fraction containing Hb was then purified on a Superose-12 HR 10/30 column on a Pharmacia FPLC system (Pharmacia, Uppsala, recombinant a gene. This plasmid contains the full-length a-globin cDNA under transcriptional control of a pGGAP promoter. The two Sweden) and eluted with 120 mmol/L Tris-Ac buffer, pH 7.5, at a flow rate of 0.4 mL/min. The concentrated Hb sample was applied synthetic oligonucleotides (5-CAC GTG GAC TAC ATG CCC AAC G and 5-C GTT GGG CAT GTA GTC CAC GTG) were in 100 mL each, and the absorbance was measured at 280 nm with the Pharmacia on-line mercury lamp detection system with a 5-mm used for the PCR amplifications, and the underlined bases were those used to create the desired mutation. The PCR amplifications were flow cell. The Hb quadruple mutant eluted at 13.6 mL as a tetramer and was collected for all structural and functional study. performed under conditions similar to those described above. From the recombinant a-globin gene containing the mutation, the Nco I Preparation of mouse hemolyzate and purification of Hb SAD. The RBCs were collected by centrifugation of a blood sample from and Sal I fragment was excised and used to replace the Nco I and Sal I fragment of pAD190. The recombinant plasmid with desired the normal mouse or SAD mouse. Lysis of the cells was achieved by addition of 2 vol of distilled water and freeze/thawing of the mutation was identified directly by DNA sequence analysis and the base change encoding the Asp75 (a) r Tyr was the only mutasuspension. After centrifugation in a microcentrifuge for 20 minutes for removal of RBC debris, the mouse hemolyzate was dialyzed tion of the a-globin gene. The Sph I fragment of plasmid pGS189 E6V(b)/E121R(b) was excised and inserted into Sph I site of pADagainst 0.1 mol/L NaCl and stored at 080ЊC until further use. Hb SAD was purified from SAD mouse hemolysate on Mono-S (Phar-190 D75Y(a) to produce a plasmid with a-and b-genes, pAD190
. This a and b cassette was excised as Not I fragment macia, Piscataway, NJ) using 100 mmol/L phosphate, pH 6.3, and an NaCl gradient from 0 to 30 mmol/L. Its purity was ascertained and similarly inserted into the Not I site of pGS389 to give the recombinant plasmid, pGS389
by the presence of only one band upon isoelectric focusing.
Analytical methods. Sodium dodecyl sulfate-polyacrylamide gel PCR-based site-directed mutagenesis of the quadruple HbS mutant D6A(a)D75Y(a)/E6V(b)/E121R(b). Two overlapping PCR
electrophoresis (SDS-PAGE) of the recombinant mutants was performed on the Phast System from Pharmacia Biotech. The protein products were synthesized using the 5-ATA AAC CAT GGT GCT GTC TCC TGC CGC CAA GAC C and 5-C GTT GGG CAT GTA bands were stained with Coomassie brilliant blue R-250. Isoelectric AID Blood 0016 / 5h43$$$301 10-30-97 01:28:15 blda WBS: Blood focusing was performed on the pH 7-10 Hb-Resolve system from gel under the oil layer was disrupted with a narrow wire loop, and the tubes were centrifuged in a microcentrifuge for 30 minutes. The Isolab. The a-and b-globin chains from recombinant Hbs were separated by reverse phase high-performance liquid chromatography clear supernatant was carefully separated from the aggregated Hb and its Hb concentration was measured spectrophotometrically and (HPLC) on a Vydac C 4 column with a gradient of 20% to 60% acetonitrile containing 0.1% trifluoroacetic acid. The effluent was verified by amino acid analysis after acid hydrolysis of an aliquot. 
15-18
However, these HbS mutants were relatively basic compared with HbS, so a gradient of high pH and increased ionic strength was required to elute them from the cation exchange column. For elution of the double mutant, a gradient of up to 25 mmol/L phosphate at pH 8.0 was used instead of 15 mmol/L phosphate for the purification of HbS. For the triple mutant, the purification was achieved on CM-Cellulose 52 using a gradient of up to 50 mmol/L phosphate at pH 8.5. The quadruple mutant was initially purified on CM 52 using a gradient of up to 50 mmol/L phosphate at pH 8.5 and further purified using Superose-12 gel filtration chromatography to remove several minor nonheme protein components that coeluted with the Hb mutant. The purity of each mutant was verified by SDS-PAGE, isoelectric focusing, globin chain analysis, and mass spectrometric analysis, as described below.
Isoelectric focusing (IEF).
Analysis of the purified recombinant mutants by IEF was performed on the pH 7 to 10 Hb-Resolve system from Isolab (Akron, OH) [15] [16] [17] [18] because of the basic nature of these mutants (Fig 1) . For the double mutant E6V(b)/E121R(b), the loss of one negative charge (Glu r Val) and a substitution equivalent to the loss of two negative charges (Glu r Arg) per subunit was confirmed by the IEF migrations, ie, there is one charge difference between HbA (lane 1) and HbS (lane 2) and two charge differences between HbS and the double mutant (lane 3). The triple mutant D75Y(a)/E6V(b)/E121R(b) has a mutation site in which Asp of its a subunit has been replaced by Tyr. Its migration on IEF was consistent with a loss of a negative charge between the double mutant and triple mutant (lane 4). Compared with the triple mutant, IEF of the quadruple mutant D6A(a)/D75Y(a)/E6V(b)/E121R(b) indicated an additional loss of a negative charge (lane 5), consistent with an additional mutation site in which Asp of its a subunit has been replaced by Ala. Because all four mutations are on the exterior of the Hb, the full effect of these pK a changes is reflected in their electrophoretic behavior.
HPLC analysis of globin chains and amino acid analysis. The purified recombinant HbS mutants were analyzed by reverse-phase HPLC using a denaturing solvent to separate the globin chains (Fig 2) . The b-chain of the double mutant E6V(b)/E121R(b) eluted at 42.9 minutes, much faster than the normal b-chain from HbS (47.6 minutes), indicating that replacement of Glu by Arg at 121 position significantly The a-and b-chains of the recombinant mutants isolated position of the a-chains from these recombinant mutants by HPLC on Vydac C 4 as described above were subjected coincided with the a-chain from natural HbS (51.8, 52.6, to amino acid analysis, which permitted their assignments 53.1, and 51.9 minutes, respectively), indicating that the re- (Tables 1, 2 , and 3). For the mutated b-chain of the double placement of the hydrophilic residue Asp at the a-chain mutant (Table 1) , the mutated a-chain of the triple mutant by nonpolar amino acids Ala and Tyr does not alter their (Table 2) , and the doubly mutated a-chain of the quadruple chromatographic behavior significantly on the reverse-phase mutant ( tion of 0.6 mmol/L ( Table 5 ). The oxygen affinity of the fold similar to that of HbS. However, the quadruple mutant
The value found for Leu was set at the theoretical value of 18.0 and shows a somewhat decreased response to chloride. The rea- (Table 6 ). The gelation concentration of the there are significant differences between the amounts in the a-and b-chains.
HbS was 35.3 mg/mL, consistent with the value of HbS (34 mg/mL) reported previously. 22 Under the same conditions, values for the other amino acids were also in good agreement confirmed their purity as a basis for the polymerization studies below. Table   Asx for a b-chain having the two substitutions (Glu r Val, Glu mal mouse Hb on the polymerization tendency of these re-
The value found for Leu was set at the theoretical value of 18.0 and combinant mutants, we have measured gelation concentra- with two equivalents of mouse hemolysate, the mixture polymerizes at a Hb concentration close to that of HbS alone. The gelation concentration of equimolar mixture of the triple the double mutant E6V(b)/E121R(b) polymerizes at a conmutant with normal mouse Hb is much lower than that of centration of 24.3 mg/mL, indicating a one third lowering sickle Hb. For the quadruple mutant, equimolar mixture with of the gelation of HbS itself. The triple mutant shows a mouse hemolysate has a gelation concentration of 12.4 mg/ doubling of this enhancement of gelation, ie, it gels at 11.8 mL, which is one third the polymerization concentration of mg/mL, which is a two thirds lower concentration than that HbS itself. of HbS itself. The average C sat of the quadruple mutant was 7.0 mg/mL, which is close to that of the purified SAD Hb DISCUSSION (6.1 mg/mL). This value is one fifth the polymerization conUsing recombinant DNA techniques, we have previously centration of HbS itself. These results show that the polymershown that inhibition of polymerization of HbS was depenization can be significantly enhanced by selected amino acid dent on the site of the amino acid substitution. 17, 18, 22, 25 Fursubstitution on various regions of the HbS tetramer. Substituthermore, we found that substitution at one particular site tion at these widely separated sites (aD6A, aD75Y, and on the exterior of the HbS tetramer inhibited polymerizabE121R) on the a-and b-chains gives rise to linearly addition 17 more than a substitution at the initial hydrophobic tive effects on the overall process of HbS polymerization interaction itself between Val-6(b) and Leu-88(b) on adja- (Fig 3) . The importance of this observation as a basis for cent tetramer 25 and that they acted independently. 22 Those further studies is described in the Discussion.
Polymerization of the mixture of recombinant mutants and There is an error of 3 or 4 mass units in the measured mass of both All measurements were performed in the presence of dextran in 50 mmol/L potassium phosphate buffer, pH 7.5, at 37ЊC, as described in a-and b-chains. It is a systematic error, so we can safely conclude that mutations were successful and that the Hbs were expressed properly. the text. The average values are in parentheses.
AID Blood 0016 / 5h43$$$301 10-30-97 01:28:15 blda WBS: Blood tetramers, the mechanism of the polymerization-enhancing tempt in that direction.
mmol/L potassium phosphate buffer, pH 7.5, at 37ЊC, as described in
In choosing the replacement sites for the double, triple, the text.
and quadruple mutants of HbS described in this report, we used the naturally occurring single and double mutants that lead to increased polymerization 12 as a guide to select the In choosing the third and fourth replacement site for the mutation sites and to achieve the additive effect. Hb D-Los triple and quadruple mutants, we selected the sites on the aAngeles (Hb D-Punjab), which is part of the SAD mouse chain distant from the substitution in the b-chain anticipating construct, has a Gln substitution for Glu at b121. Its presence that an additive effect on the enhanced polymerization may in the RBC together with HbS led to a more severe clinical be obtained. 28 We reasoned that the respectively. 30 In this instance, we saw no advantage in subsubstitution for Glu at b121 by an even larger basic amino stituting an amino acid different than that occurring natuacid could stabilize the polymer structure to an even greater rally. This strategy has been borne out, because the triple extent. Therefore, Arg was selected to achieve this effect. mutant D75Y(a)/E6V(b)/E121R(b) has doubled the enOur results show that the double mutant E6V(b)/E121R(b) hanced polymerization of the mutant E6V(b)/E121R(b) and polymerizes at about one third lower Hb concentration than it gels at a Hb concentration that is two thirds less than HbS. This value is comparable to that from natural double HbS itself. For the quadruple mutant, the polymerization mutant HbS-Oman, suggesting that the enhancing effect is concentration (7.0 mg/mL) is about 40% lower than that of retained by the introduction of a more basic amino acid triple mutant D75Y(a)/E6V(b)/E121R(b). Thus, the substiresidue and the size of the residue at this site does not play tution of Ala for Asp at a6 further decreased the solubility a significant role in the polymerization process of HbS.
of the HbS triple mutant by about 40%. These results not only show the overall enhanced effects but also the individual contribution of different sites on HbS polymerization. The findings demonstrate the feasibility of expressing multiple HbS mutants in the yeast system to understand the sites that lead to an enhanced polymerization as well as those that give a decreased polymerization. 17, 22, 25 The comparison of the polymerization concentration of the recombinant mutants with that of the purified SAD Hb indicates a progressive tendency towards the latter (Fig 3) . Because the polymerization concentration of the purified SAD Hb has not yet been reported at physiologic concentrations to our knowledge, it is useful to have this information as a point of reference. An important conclusion of these studies is that recombinant higher order sickle Hb mutants can be selected beginning with the fundamental knowledge of the gelation concentration of the natural HbS double mutants as a guide. 12 Thus, the finding that the polymerization concentration of the quadruple mutant is virtually the same as that of the triple SAD mutant purified from the transgenic mouse indicates that the experimental approach is logical. This result also suggests 
